Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-23-001008
Filing Date
2023-09-26
Accepted
2023-09-26 17:09:17
Documents
39
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q restez20230925_10q.htm   iXBRL 10-Q 297546
2 EXHIBIT 31.1 ex_573129.htm EX-31.1 10295
3 EXHIBIT 31.2 ex_573130.htm EX-31.2 10199
4 EXHIBIT 32.1 ex_573131.htm EX-32.1 5307
5 EXHIBIT 32.2 ex_573132.htm EX-32.2 5511
  Complete submission text file 0001185185-23-001008.txt   1582110

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA rest-20230630.xsd EX-101.SCH 19296
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rest-20230630_cal.xml EX-101.CAL 13481
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rest-20230630_def.xml EX-101.DEF 70329
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rest-20230630_lab.xml EX-101.LAB 147004
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rest-20230630_pre.xml EX-101.PRE 76308
33 EXTRACTED XBRL INSTANCE DOCUMENT restez20230925_10q_htm.xml XML 78458
Mailing Address 263 EAST 8680 SOUTH SANDY UT 84070
Business Address 263 EAST 8680 SOUTH SANDY UT 84070 888-202-9256
REST EZ Inc. (Filer) CIK: 0001733861 (see all company filings)

EIN.: 824268982 | State of Incorp.: WY | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-56447 | Film No.: 231281177
SIC: 2834 Pharmaceutical Preparations